| For: | Tarantino G, Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol 2013; 19(22): 3375-3384 [PMID: 23801829 DOI: 10.3748/wjg.v19.i22.3375] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i22/3375.htm |
| Number | Citing Articles |
| 1 |
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas. 2018; doi: 10.7476/9786588211113.0007
|
| 2 |
Ivana Mikolasevic, Andela Lukic, Toni Juric, Mia Klapan, Petra Madzar, Nikola Krolo, Doris Kolovrat, Ivanka Jurica, Iva Kedmenec, Domagoj Kihas, Doris Ilovaca, Ivan Erstic, Vanda Haralovic, Danijel Cavlina, Ema Dejhalla, Danijela Erdeljac, Benjamin Vukalovic, Nadija Skenderevic, Sandra Milic. Non-alcoholic fatty liver disease and transient elastography. Exploration of Medicine 2020; 1(4) doi: 10.37349/emed.2020.00014
|
| 3 |
Eylem Özten, Sermin Kesebir, Gül Eryılmaz, Nevzat Tarhan, Oğuz Karamustafalıoğlu. RETRACTED: Are uric acid plasma levels different between unipolar depression with and without adult attention deficit hyperactivity disorder?. Journal of Affective Disorders 2015; 177 doi: 10.1016/j.jad.2015.01.047
|
| 4 |
Marieke de Vries, Jan Westerink, Karin H A H Kaasjager, Harold W de Valk. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 2020; 105(12) doi: 10.1210/clinem/dgaa575
|
| 5 |
Diego Germano Maia, Kristopherson Lustosa Augusto, Mailze Campos Bezerra, Carlos Ewerton Maia Rodrigues. Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNFα therapy: association with predictors of cardiovascular risk. Clinical Rheumatology 2017; 36(10) doi: 10.1007/s10067-017-3623-8
|
| 6 |
Keywan Mortezaee, Fatemeh Sabbaghziarani, Ameneh Omidi, Ahmad Reza Dehpour, Negar Omidi, Soudabeh Ghasemi, Parichehr Pasbakhsh, Iraj Ragerdi Kashani. Therapeutic value of melatonin post-treatment on CCl4-induced fibrotic rat liver. Canadian Journal of Physiology and Pharmacology 2016; 94(2) doi: 10.1139/cjpp-2015-0266
|
| 7 |
Shudi Li, Fei Duan, Suling Li, Baoping Lu. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis. Annals of Hepatology 2024; 29(2) doi: 10.1016/j.aohep.2023.101174
|
| 8 |
Shukang Wang, Chengqi Zhang, Guang Zhang, Zhongshang Yuan, Yanxun Liu, Lijie Ding, Xiubin Sun, Hongying Jia, Fuzhong Xue. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open 2016; 6(6) doi: 10.1136/bmjopen-2015-010342
|
| 9 |
Carmine Finelli, Maria Carmela Padula, Giuseppe Martelli, Giovanni Tarantino. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?. World Journal of Gastroenterology 2014; 20(44): 16649-16664 doi: 10.3748/wjg.v20.i44.16649
|
| 10 |
Giovanni Tarantino, Susan Costantini, Carmine Finelli, Francesca Capone, Eliana Guerriero, Nicolina La Sala, Saverio Gioia, Giuseppe Castello, Kottarappat N. Dileepan. Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease. PLoS ONE 2014; 9(9) doi: 10.1371/journal.pone.0105610
|
| 11 |
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2) doi: 10.1016/j.bbadis.2017.11.026
|
| 12 |
Bobae Kim, Rwubuzizi Ronaldo, Beet-Na Kweon, Solhee Yoon, Yein Park, Jea-Hyun Baek, Jung Min Lee, Chang-Kee Hyun. Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis. International Journal of Molecular Sciences 2024; 25(19) doi: 10.3390/ijms251910447
|
| 13 |
Anubhav Mondal, Aninda Debnath, Ghurumourthy Dhandapani, Abhishek Sharma, Shveta Lukhmana, Geeta Yadav. Prevalence of High and Moderate Risk of Liver Fibrosis Among Patients With Diabetes at a Noncommunicable Diseases (NCD) Clinic in a Primary Healthcare Center in Northern India. Cureus 2023; doi: 10.7759/cureus.49286
|
| 14 |
Ayaka Iida, Ena Takahashi, Sachi Kuranuki, Shu Shimamoto, Tsuyoshi Nakamura, Hiroshi Kitagaki. Water-Soluble Cellulose Acetate Changes the Intestinal Microbiota in Mice with Non-Alcoholic Steatohepatitis. Nutrients 2025; 17(3) doi: 10.3390/nu17030500
|
| 15 |
Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.774030
|
| 16 |
Sujoy Majumdar, Jubbin J. Jacob, Edward B. Jude. Metabolic Syndrome. 2024; doi: 10.1016/B978-0-323-85732-1.00054-2
|
| 17 |
CP Onyenekwu, AO Dada, OT Babatunde. The Prevalence of Metabolic Syndrome and its Components among Overweight and Obese Nigerian Adolescents and Young Adults. Nigerian Journal of Clinical Practice 2017; 20(6) doi: 10.4103/1119-3077.196085
|
| 18 |
Sujana S Gunta, Robert H Mak. Hypertension in children with obesity. World Journal of Hypertension 2014; 4(2): 15-24 doi: 10.5494/wjh.v4.i2.15
|
| 19 |
Akinobu Nakamura, Yasuo Terauchi. Lessons from Mouse Models of High-Fat Diet-Induced NAFLD. International Journal of Molecular Sciences 2013; 14(11) doi: 10.3390/ijms141121240
|
| 20 |
Hyun-Seok Kim, Laura Rotundo, Neil Kothari, Sung-Hoon Kim, Nikolaos Pyrsopoulos. Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based Study. Journal of Clinical and Translational Hepatology 2017; (XX) doi: 10.14218/JCTH.2017.00025
|
| 21 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; doi: 10.1016/B978-1-63067-036-8.00028-7
|
| 22 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 23 |
Myungsuk Kim, Young Gyun Park, Hee-Ju Lee, Sue Ji Lim, Hong Ryul Ahn, Sang Hoon Jung, Chu Won Nho. Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolism. Journal of Functional Foods 2015; 18 doi: 10.1016/j.jff.2015.09.002
|
| 24 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5) doi: 10.3390/ijms19051308
|
| 25 |
Keith Pereira, Jason Salsamendi, Javier Casillas. The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. Journal of Clinical Imaging Science 2015; 5 doi: 10.4103/2156-7514.157860
|
| 26 |
Ludovico Abenavoli, Valentina Peta, Natasa Milic. Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. Annals of Hepatology 2015; 14(1) doi: 10.1016/S1665-2681(19)30809-9
|
| 27 |
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
|
| 28 |
Asuman Celikbilek, Mehmet Celikbilek, Gurbet Bozkurt. Cognitive assessment of patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2018; 30(8) doi: 10.1097/MEG.0000000000001131
|
| 29 |
T.I. Yefimenko, M.R. Mykytyuk. Non-alcoholic fatty liver disease: time for changes. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2021; 17(4) doi: 10.22141/2224-0721.17.4.2021.237350
|
| 30 |
Chun Pei, Chung-Ze Wu, Chang-Hsun Hsieh, Jin-Biou Chang, Yao-Jen Liang, Yen-Lin Chen, Dee Pei, Jiunn-Diann Lin. Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals. Metabolic Syndrome and Related Disorders 2019; 17(9) doi: 10.1089/met.2019.0032
|
| 31 |
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer. 2018; doi: 10.5772/intechopen.80527
|
| 32 |
Rahman G. Barry, Farzad A. Amiri, Todd W. Gress, D. Blaine Nease, Timothy D. Canterbury. Laparoscopic vertical sleeve gastrectomy. Medicine 2017; 96(35) doi: 10.1097/MD.0000000000007508
|
| 33 |
Chih-Weim Hsiang, Chang-Hsien Liu, Hsiu-Lung Fan, Kai-Hsiung Ko, Chih-Yung Yu, Hong-Hau Wang, Wen-I Liao, Hsian-He Hsu, Wei-Chou Chang. Clinical Features and Computed Tomography Characteristics of Non-Klebsiella pneumoniaeLiver Abscesses in Elderly (>65 Years) and Nonelderly Patients. Yonsei Medical Journal 2015; 56(2) doi: 10.3349/ymj.2015.56.2.519
|
| 34 |
Dong Wook Jeong, Hye Won Lee, Young Hye Cho, Dong Won Yi, Sang Yeoup Lee, Seok Man Son, Yang Ho Kang. Comparison of Serum Ferritin and Vitamin D in Association with the Severity of Nonalcoholic Fatty Liver Disease in Korean Adults. Endocrinology and Metabolism 2014; 29(4) doi: 10.3803/EnM.2014.29.4.479
|
| 35 |
I. Aldhoon-Hainerová, V. Hainer, H. Zamrazilová. Impact of dietary intake, lifestyle and biochemical factors on metabolic health in obese adolescents. Nutrition, Metabolism and Cardiovascular Diseases 2017; 27(8) doi: 10.1016/j.numecd.2017.05.002
|
| 36 |
Karen Klepsland Mauland, Øyvin Eng, Sigmund Ytre-Hauge, Ingvild L. Tangen, Anna Berg, Helga B. Salvesen, Øyvind O. Salvesen, Camilla Krakstad, Jone Trovik, Erling A. Hoivik, Henrica Maria Johanna Werner, Gunnar Mellgren, Ingfrid S. Haldorsen. High visceral fat percentage is associated with poor outcome in endometrial cancer. Oncotarget 2017; 8(62) doi: 10.18632/oncotarget.21917
|
| 37 |
Mohamed Zaiou, Rim Amrani, Bertrand Rihn, Tahar Hajri. Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. Biomedicines 2021; 9(9) doi: 10.3390/biomedicines9091256
|
| 38 |
Carmen Alejandrina Virgen-Carrillo, Diana Laura Hernández de los Ríos, Karina Ruíz Torres, Alma Gabriela Martínez Moreno. Diagnostic Criteria for Metabolic Syndrome in Diet-Induced Rodent Models: A Systematic Review. Current Diabetes Reviews 2021; 17(8) doi: 10.2174/1573399817666210414103730
|
| 39 |
Elena Omelchenko, Dov Gavish, Marina Shargorodsky. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. Journal of the American Society of Hypertension 2014; 8(6) doi: 10.1016/j.jash.2014.03.002
|
| 40 |
Shudi Li, Suling Li, Fei Duan, Baoping Lu. Depression and NAFLD risk: A meta-analysis and Mendelian randomization study. Journal of Affective Disorders 2024; 352 doi: 10.1016/j.jad.2024.02.074
|
| 41 |
C-X Xu, C Wang, Z-M Zhang, C D Jaeger, S L Krager, K M Bottum, J Liu, D-F Liao, S A Tischkau. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure. International Journal of Obesity 2015; 39(8) doi: 10.1038/ijo.2015.63
|
| 42 |
M. Georgoulis, M. D. Kontogianni, A. Margariti, D. Tiniakos, E. Fragopoulou, R. Zafiropoulou, G. Papatheodoridis. Associations between dietary intake and the presence of the metabolic syndrome in patients with non‐alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics 2015; 28(4) doi: 10.1111/jhn.12323
|
| 43 |
Chih-Cheng Lai, Chung-Han Ho, Kuo-Chen Cheng, Chien-Ming Chao, Chin-Ming Chen, Willy Chou. Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: A population-based study. World Journal of Gastroenterology 2017; 23(12): 2201-2208 doi: 10.3748/wjg.v23.i12.2201
|
| 44 |
Cai-Ren Wang, Hong-Wei Chen, Yan Li, Ming-Yue Zhou, Vincent Kam-Wai Wong, Zhi-Hong Jiang, Wei Zhang. Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols. Nutrients 2021; 13(11) doi: 10.3390/nu13114060
|
| 45 |
Wen-Yuan Lin, Cheng-Yuan Peng, Cheng-Chieh Lin, Lance E. Davidson, F. Xavier Pi-Sunyer, Pei-Kun Sung, Kuo-Chin Huang. General and Abdominal Adiposity and Risk of Death in HBV Versus Non-HBV Carriers. Medicine 2016; 95(2) doi: 10.1097/MD.0000000000002162
|
| 46 |
Hayam Ateyya, Manar A. Nader, Nagla A. El-Sherbeeny. Beneficial effects of rosiglitazone and losartan combination in diabetic rats. Canadian Journal of Physiology and Pharmacology 2018; 96(3) doi: 10.1139/cjpp-2017-0332
|
| 47 |
Seyedeh Parisa Moosavian, Arman Arab, Zamzam Paknahad. The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Clinical Nutrition ESPEN 2020; 35 doi: 10.1016/j.clnesp.2019.10.008
|
| 48 |
Anna Pastore, Anna Alisi, Gianna Di Giovamberardino, Annalisa Crudele, Sara Ceccarelli, Nadia Panera, Carlo Dionisi-Vici, Valerio Nobili. Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage. International Journal of Molecular Sciences 2014; 15(11) doi: 10.3390/ijms151121202
|
| 49 |
Ajit Ramakant Mahale, Sonali Dattatray Prabhu, Muthiah Nachiappan, Merwyn Fernandes, Sonali Ullal. Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups. Journal of International Medical Research 2018; 46(11) doi: 10.1177/0300060518793039
|
| 50 |
Yi Liu, Xianda Che, Wei Wei, Chong Teng, Huimin Li. Mitochondria‑endoplasmic reticulum contact site nexus: Molecular integration, disease pathogenesis and therapeutic opportunities (Review). International Journal of Molecular Medicine 2026; 58(2) doi: 10.3892/ijmm.2026.5898
|
| 51 |
Clarissa Elysia Fu, Jie Ning Yong, Cheng Han Ng, Benjamin Nah, Nicholas W. S. Chew, Yip Han Chin, Gwyneth Kong, Darren Jun Hao Tan, Wen Hui Lim, Lincoln Kai En Lim, Rebecca Wenling Zeng, Asim Shabbir, Eunice X. X. Tan, Daniel Q. Huang, Chin Meng Khoo, Mohammad Shadab Siddqui, Mark Y. Y. Chan, Mazen Noureddin, Mamas A. Mamas, Mark Muthiah. The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome. Alimentary Pharmacology & Therapeutics 2023; 57(9) doi: 10.1111/apt.17397
|
| 52 |
Daria Skuratovskaia, Aleksandra Komar, Maria Vulf, Hung Vu Quang, Egor Shunkin, Larisa Volkova, Natalia Gazatova, Pavel Zatolokin, Larisa Litvinova. IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22041774
|
| 53 |
Peipei Wu, Qicai Chen, Lili Chen, Pengpeng Zhang, Juan Xiao, Xiaoxiao Chen, Meng Liu, Shumei Wang. Dose-Response Relationship between Alanine Aminotransferase Levels within the Reference Interval and Metabolic Syndrome in Chinese Adults. Yonsei Medical Journal 2017; 58(1) doi: 10.3349/ymj.2017.58.1.158
|
| 54 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Management of fatty liver disease with the metabolic syndrome. Expert Review of Gastroenterology & Hepatology 2014; 8(5) doi: 10.1586/17474124.2014.903798
|
| 55 |
Carlotta Lassandro, Giuseppe Banderali, Giovanni Radaelli, Elisa Borghi, Francesca Moretti, Elvira Verduci. Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?. International Journal of Molecular Sciences 2015; 16(8) doi: 10.3390/ijms160819989
|
| 56 |
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population. Hepatology Communications 2019; 3(1) doi: 10.1002/hep4.1285
|
| 57 |
Lu Han, Stefanie Bittner, Dachuan Dong, Yuan Cortez, Hunter Dulay, Sara Arshad, Wen-Jun Shen, Fredric B. Kraemer, Salman Azhar. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Molecular and Cellular Endocrinology 2019; 498 doi: 10.1016/j.mce.2019.110538
|
| 58 |
Bo Liu, Honghui Yin, Yaxiong Li, Guojiang Mao, Sheng Yang, Kai Zhang. Recent Advances in Small Molecular Fluorescence Probes for Fatty Liver Diseases. Chemosensors 2023; 11(4) doi: 10.3390/chemosensors11040241
|
| 59 |
Hongling Li, Jin Li. Application of real-time contrast-enhanced ultrasound in differential diagnosis of liver malignancies. Canadian Journal of Physiology and Pharmacology 2019; 97(5) doi: 10.1139/cjpp-2018-0404
|
| 60 |
Mei-Chih Tsai, Shih-Chien Huang, Wei-Tang Chang, Shiuan-Chih Chen, Chin-Lin Hsu. Effect of Astaxanthin on the Inhibition of Lipid Accumulation in 3T3-L1 Adipocytes via Modulation of Lipogenesis and Fatty Acid Transport Pathways. Molecules 2020; 25(16) doi: 10.3390/molecules25163598
|
| 61 |
Abraham Khan, Aram Kim, Cassandra Sanossian, Fritz Francois. Impact of obesity treatment on gastroesophageal reflux disease. World Journal of Gastroenterology 2016; 22(4): 1627-1638 doi: 10.3748/wjg.v22.i4.1627
|
| 62 |
Ludovico Abenavoli, Natasa Milic, Valentina Peta, Francesco Alfieri, Antonino De Lorenzo, Stefano Bellentani. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World Journal of Gastroenterology 2014; 20(45): 16831-16840 doi: 10.3748/wjg.v20.i45.16831
|
| 63 |
Raquel Coronato Nunes, Ana Luiza Gomes Moura, Arthur Lawall Silva, Gustavo Gusman Oliveira, Luisa Artiaga Malta, Rodrigo Oliveira Moreira. Avaliação da frequência de deficiência de vitamina D em pacientes com obesidade. HU Revista 2019; 44(2) doi: 10.34019/1982-8047.2018.v44.13966
|
| 64 |
Amal M. Shoeib, Eman Said, Elsayed M. Ammar. Cytoprotective potential of tiron and methyl palmitate against acetaminophen-induced acute liver injury. Canadian Journal of Physiology and Pharmacology 2016; 94(2) doi: 10.1139/cjpp-2015-0270
|
| 65 |
Juan Li, Shuang Li, Xiuli Wang, Hongxin Wang. Esculetin induces apoptosis of SMMC-7721 cells through IGF-1/PI3K/Akt-mediated mitochondrial pathways. Canadian Journal of Physiology and Pharmacology 2017; 95(7) doi: 10.1139/cjpp-2016-0548
|
| 66 |
Nima Motamed, Masoudreza Sohrabi, Hossein Ajdarkosh, Gholamreza Hemmasi, Mansooreh Maadi, Fatemeh Sima Sayeedian, Reza Pirzad, Khadijeh Abedi, Sivil Aghapour, Mojtaba Fallahnezhad, Farhad Zamani. Fatty liver index <i>vs</i> waist circumference for predicting non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(10): 3023-3030 doi: 10.3748/wjg.v22.i10.3023
|
| 67 |
Petra Surlin, Andreea Cristiana Didilescu, Luminita Lazar, Cristian Cosmin Arsenie, Adrian Camen, Dora Maria Popescu, Dorin Nicolae Gheorghe, Eugen Osiac, Ion Rogoveanu. Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S310314
|
| 68 |
Xiao-Yue Wang, Xiang-Hua Zhang, Chao Yao, Hong-Hui Zhu, Liang Zhang. The Impacts of Obesity and Metabolic Abnormality on Carotid Intima-Media Thickness and Non-Alcoholic Fatty Liver Disease in Children from an Inland Chinese City. Journal of Clinical Medicine 2014; 3(1) doi: 10.3390/jcm3010323
|
| 69 |
Jihye Hong, Sera Kim, Hyun-Sook Kim. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. Journal of Medicinal Food 2016; 19(6) doi: 10.1089/jmf.2015.3604
|
| 70 |
Zhengtao Liu, Huaijun Ning, Xiaoyin He, Shuping Que, Lin Zhou.
Meta-Analysis Reveals a Specific Association of the
Pnpla3
I148M Polymorphism with Alt Level in Adolescents
. Personalized Medicine 2015; 12(2) doi: 10.2217/pme.14.72
|
| 71 |
Oladayo E. Apalowo, Meghan O’Dwyer, Edirisa J. Nsubuga, Leah Pylate, Abeer M. Alardawi, Nicole Reeder, Frank Kiyimba, Terezie Tolar-Peterson, Wes Schilling, Joel J. Komakech. Gender-Specific Interactions Between Adiposity, Alcohol Consumption, and Biological Stress Biomarkers Among College Students in the United States. Nutrients 2025; 17(16) doi: 10.3390/nu17162640
|
| 72 |
Bo Yang, Huaguan Lu, Yinghui Ran. Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1450317
|
| 73 |
Atefeh Akrami, Farzad Nikaein, Siavash Babajafari, Shiva Faghih, Hassan Yarmohammadi. Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome. Journal of Clinical Lipidology 2018; 12(1) doi: 10.1016/j.jacl.2017.11.004
|
| 74 |
Sang R. Lee, Sun Woo Kwon, Pelin Kaya, Young Ho Lee, Jong Geol Lee, Globinna Kim, Geun-Shik Lee, In-Jeoung Baek, Eui-Ju Hong. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34148-6
|
| 75 |
Xiaoyu Lv, Chenyu Nie, Yihan Shi, Qincheng Qiao, Jing Gao, Ying Zou, Jingwen Yang, Li Chen, Xinguo Hou. Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02382-9
|
| 76 |
Nagla A. El-Sherbeeny, Manar A. Nader. The protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity. Canadian Journal of Physiology and Pharmacology 2016; 94(3) doi: 10.1139/cjpp-2015-0336
|
| 77 |
Fahimeh Haghighatdoost, Masoud Amini, Awat Feizi, Bijan Iraj. Are body mass index and waist circumference significant predictors of diabetes and prediabetes risk: Results from a population based cohort study. World Journal of Diabetes 2017; 8(7): 365-373 doi: 10.4239/wjd.v8.i7.365
|
| 78 |
Tao Zhang, Chengqi Zhang, Yongyuan Zhang, Fang Tang, Hongkai Li, Qian Zhang, Haiyan Lin, Shuo Wu, Yanxun Liu, Fuzhong Xue. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study. Atherosclerosis 2015; 240(1) doi: 10.1016/j.atherosclerosis.2015.02.049
|
| 79 |
Hu Chen, Xiang Ding, Jiatian Li, Ziying Wu, Yuqing Wang, Hongyi He, Zidan Yang, Jing Wu, Yilun Wang, Dongxing Xie. White blood cell count: an independent predictor of coronary heart disease risk in middle-aged and elderly population with hyperuricemia. Medicine 2018; 97(51) doi: 10.1097/MD.0000000000013729
|
| 80 |
Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis. Journal of Interferon & Cytokine Research 2024; 44(3) doi: 10.1089/jir.2023.0162
|
| 81 |
Giovanni Tarantino, Carmine Finelli. Systematic review on Intervention with Prebiotics/Probiotics in Patients with Obesity-Related Nonalcoholic Fatty liver Disease. Future Microbiology 2015; 10(5) doi: 10.2217/fmb.15.13
|
| 82 |
Kozma Bela, Pop Crina, Petrut Madalina, Drasovean Silvia, Dobru Daniela. Is NAFLD a Risk Factor for Colorectal Polyps? An Analysis of Single Romanian Centre. Acta Medica Marisiensis 2015; 61(3) doi: 10.1515/amma-2015-0065
|
| 83 |
Yunqi Li, Ying Gu, Qingming Luo, Xingde Li, Ying Gu, Dan Zhu. Application and development of phototherapy for metabolic associated disease. Optics in Health Care and Biomedical Optics XII 2022; doi: 10.1117/12.2642271
|
| 84 |
Julie Lasselin, Eric Magne, Cédric Beau, Patrick Ledaguenel, Sandra Dexpert, Agnès Aubert, Sophie Layé, Lucile Capuron. Adipose Inflammation in Obesity: Relationship With Circulating Levels of Inflammatory Markers and Association With Surgery-Induced Weight Loss. The Journal of Clinical Endocrinology & Metabolism 2014; 99(1) doi: 10.1210/jc.2013-2673
|
| 85 |
Min-Kyung Lee, Eun-Jung Rhee, Min Chul Kim, Byung Sub Moon, Jeong In Lee, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee. Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study. Endocrinology and Metabolism 2015; 30(4) doi: 10.3803/EnM.2015.30.4.522
|
| 86 |
Carlos J. Pirola, Romina Scian, Tomas Fernández Gianotti, Hernán Dopazo, Cristian Rohr, Julio San Martino, Gustavo O. Castaño, Silvia Sookoian. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease. Medicine 2015; 94(36) doi: 10.1097/MD.0000000000001480
|
| 87 |
Xin Xin, Cheng Chen, Yi-Yang Hu, Qin Feng. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomedicine & Pharmacotherapy 2019; 117 doi: 10.1016/j.biopha.2019.109047
|
| 88 |
Chiara Gelli, Mirko Tarocchi, Ludovico Abenavoli, Laura Di Renzo, Andrea Galli, Antonino De Lorenzo. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(17): 3150-3162 doi: 10.3748/wjg.v23.i17.3150
|
| 89 |
Jayagopalan Veena, Anjaneyulu Muragundla, Srinivas Sidgiddi, Swaminathan Subramaniam. Non-alcoholic fatty liver disease: need for a balanced nutritional source. British Journal of Nutrition 2014; 112(11) doi: 10.1017/S0007114514002591
|
| 90 |
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11) doi: 10.3390/metabo12111073
|
| 91 |
Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Rafał Filip. What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?. Life 2023; 14(1) doi: 10.3390/life14010037
|
| 92 |
Mauro Cataldi, Ornella di Geronimo, Rossella Trio, Antonella Scotti, Andrea Memoli, Domenico Capone, Bruna Guida. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy. BMC Pharmacology and Toxicology 2016; 17(1) doi: 10.1186/s40360-016-0055-z
|
| 93 |
Juvenal A. Ríos, Pedro Cisternas, Marco Arrese, Salesa Barja, Nibaldo C. Inestrosa. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. Progress in Neurobiology 2014; 121 doi: 10.1016/j.pneurobio.2014.07.004
|
| 94 |
Alexandru Popa, Felix Bende, Roxana Șirli, Alina Popescu, Victor Bâldea, Raluca Lupușoru, Radu Cotrău, Renata Fofiu, Camelia Foncea, Ioan Sporea. Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study. Diagnostics 2021; 11(5) doi: 10.3390/diagnostics11050783
|
| 95 |
Chyntia Olivia Maurine JASIRWAN, Akhmadu MURADI, Irsan HASAN, Marcellus SIMADIBRATA, Ikhwan RINALDI. Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Bioscience of Microbiota, Food and Health 2021; 40(1) doi: 10.12938/bmfh.2020-046
|
| 96 |
Huasheng Zhang, Wanyi Liu, Yuliang Chen, Yang Xiong. The J-shaped association between the ZJU index and depression: A cross-sectional study from NHANES. Medicine 2026; 105(24) doi: 10.1097/MD.0000000000049296
|
| 97 |
Carmen Fierbinteanu-Braticevici, Crina Sinescu, Alexandru Moldoveanu, Ana Petrisor, Sorina Diaconu, Dragos Cretoiu, Bogdan Braticevici. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health. Cell Biology and Toxicology 2017; 33(1) doi: 10.1007/s10565-016-9361-x
|
| 98 |
Carla Lubrano, Giuseppe Valacchi, Palma Specchia, Lucio Gnessi, Elizaveta P. Rubanenko, Elena A. Shuginina, Arseny I. Trukhanov, Liudmila G. Korkina, Chiara De Luca. Integrated Haematological Profiles of RedoxStatus, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome. Oxidative Medicine and Cellular Longevity 2015; 2015 doi: 10.1155/2015/490613
|
| 99 |
Li Wang, Zhe Wang, Meng-ming Xia, Ying-ying Wang, Hai-yun Wang, Guo-xin Hu. Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro. Canadian Journal of Physiology and Pharmacology 2014; 92(11) doi: 10.1139/cjpp-2014-0260
|
| 100 |
Lisa Kolden Midtbø, Alison G. Borkowska, Annette Bernhard, Alexander Krokedal Rønnevik, Erik-Jan Lock, Michael L. Fitzgerald, Bente E. Torstensen, Bjørn Liaset, Trond Brattelid, Theresa L. Pedersen, John W. Newman, Karsten Kristiansen, Lise Madsen. Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice. The Journal of Nutritional Biochemistry 2015; 26(6) doi: 10.1016/j.jnutbio.2014.12.005
|
| 101 |
Melanie Penke, Per S. Larsen, Susanne Schuster, Morten Dall, Benjamin A.H. Jensen, Theresa Gorski, Andrej Meusel, Sandy Richter, Sara G. Vienberg, Jonas T. Treebak, Wieland Kiess, Antje Garten. Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. Molecular and Cellular Endocrinology 2015; 412 doi: 10.1016/j.mce.2015.05.028
|
| 102 |
Antje Garten, Susanne Schuster, Melanie Penke, Theresa Gorski, Tommaso de Giorgis, Wieland Kiess. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nature Reviews Endocrinology 2015; 11(9) doi: 10.1038/nrendo.2015.117
|
| 103 |
Ludovico Abenavoli, Marta Greco, Immacolata Nazionale, Valentina Peta, Natasa Milic, Francesca Accattato, Daniela Foti, Elio Gulletta, Francesco Luzza. Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2015; 9(4) doi: 10.1586/17474124.2015.1004312
|
| 104 |
Kyung-A Byun, Seyeon Oh, Myeongjoo Son, Chul-Hyun Park, Kuk Hui Son, Kyunghee Byun. Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice. Marine Drugs 2021; 19(9) doi: 10.3390/md19090495
|
| 105 |
Ludovico Abenavoli. Non-alcoholic fatty liver disease and beneficial effects of dietary supplements. World Journal of Hepatology 2015; 7(12): 1723-1724 doi: 10.4254/wjh.v7.i12.1723
|
| 106 |
Zhifu Li, Yichen Bao, Xingpeng Yang, Yizhao Ma, Lin Qi, Xiaohui Du, Pengyue Zhao. NUFIP1 at the crossroads of ribophagy and disease: unveiling therapeutic implications. Journal of Translational Medicine 2025; 24(1) doi: 10.1186/s12967-025-07528-6
|
| 107 |
Wei Zhu, Yingzhi Liu, Konghe Hu, Wenxue Li, Jianling Chen, Juntao Li, Guangyu Yang, Jinyin Wu, Xiaoyun Liang, Chuanxi Fu, Qiansheng Hu. Vitronetcin promotes cell growth and inhibits apoptotic stimuli in a human hepatoma cell line via the activation of caspases. Canadian Journal of Physiology and Pharmacology 2014; 92(5) doi: 10.1139/cjpp-2014-0032
|
| 108 |
Abdallah H. Fathy, Mohamed A. Bashandy, Samir A.E. Bashandy, Ahmed M. Mansour, Bakheet Elsadek. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model. Canadian Journal of Physiology and Pharmacology 2017; 95(12) doi: 10.1139/cjpp-2017-0413
|
| 109 |
Qian Zhang, Carlos K H Wong, Kenny Kung, Joseph C Y Chan, Barre T W Sy, Marcus Lam, Xiang Gui Xu, Meng Feng Yang, Yang Yu, Xiu Ping Lin, Cindy L K Lam. Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China. Family Practice 2017; 34(6) doi: 10.1093/fampra/cmx049
|
| 110 |
Dan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, Qian-Di Lu, Gui-Qi Zhu, Ke-Qing Shi, Martin Braddock, Dan Song, Ming-Hua Zheng. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2016; 20(3) doi: 10.1517/14728222.2016.1096930
|
| 111 |
Asuman Celikbilek, Mehmet Celikbilek, Aylin Okur, Serkan Dogan, Elif Borekci, Mustafa Kozan, Sebnem Gursoy. Non-alcoholic fatty liver disease in patients with migraine. Neurological Sciences 2014; 35(10) doi: 10.1007/s10072-014-1798-1
|
| 112 |
Wen Chen, Huakan Zhao, Yongsheng Li. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01547-9
|
| 113 |
Stergios A. Polyzos, Christos S. Mantzoros. Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 2014; 63(2) doi: 10.1016/j.metabol.2013.10.010
|
| 114 |
Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. PLOS ONE 2017; 12(2) doi: 10.1371/journal.pone.0172000
|
| 115 |
Guoxin Huang, Hui Zhou, Chao Shen, Yihui Sheng, Ruyu Xue, Chen Dong, Shaoyan Zhang. Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults. Clinical and Experimental Hypertension 2021; 43(8) doi: 10.1080/10641963.2021.1960364
|
| 116 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; doi: 10.1016/B978-1-63067-036-8.00004-4
|
| 117 |
Enoch Cobbina, Fatemeh Akhlaghi. Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metabolism Reviews 2017; 49(2) doi: 10.1080/03602532.2017.1293683
|
| 118 |
Zhichao Zhang, Yuanxin Pang, Jun Shen, Weihai Chen, ChuanZhen Hao, Zhijun Lei. The new definition of metabolic syndrome including hyperuricemia improves its prognostic value: results from NHANES database. BMC Cardiovascular Disorders 2025; 25(1) doi: 10.1186/s12872-025-04529-7
|
| 119 |
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
|
| 120 |
Bo Yang, Xiang Zhong. Clinical model to predict the risk of nonalcoholic fatty liver disease: A secondary analysis of data from a cross-sectional study. Medicine 2024; 103(36) doi: 10.1097/MD.0000000000039437
|
| 121 |
Natasa Paklar, Maja Mijic, Tajana Filipec-Kanizaj. The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. Biomedicines 2023; 11(11) doi: 10.3390/biomedicines11113096
|